ICAM1
Intercellular adhesion molecule 1
Also known as: BB2, CD54, ICAM1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P05362
- Gene
- ICAM1
- Ensembl
- ENSG00000090339
- Chromosome
- 19
- Canonical length
- 532 aa
- Protein class
- Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Vesicles,Plasma membrane,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a cell surface glycoprotein which is typically expressed on endothelial cells and cells of the immune system. It binds to integrins of type CD11a / CD18, or CD11b / CD18 and is also exploited by Rhinovirus as a receptor. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
532 residues, UniProt reviewed canonical sequence.
>P05362|ICAM1
1 MAPSSPRPAL PALLVLLGAL FPGPGNAQTS VSPSKVILPR GGSVLVTCST SCDQPKLLGI
61 ETPLPKKELL LPGNNRKVYE LSNVQEDSQP MCYSNCPDGQ STAKTFLTVY WTPERVELAP
121 LPSWQPVGKN LTLRCQVEGG APRANLTVVL LRGEKELKRE PAVGEPAEVT TTVLVRRDHH
181 GANFSCRTEL DLRPQGLELF ENTSAPYQLQ TFVLPATPPQ LVSPRVLEVD TQGTVVCSLD
241 GLFPVSEAQV HLALGDQRLN PTVTYGNDSF SAKASVSVTA EDEGTQRLTC AVILGNQSQE
301 TLQTVTIYSF PAPNVILTKP EVSEGTEVTV KCEAHPRAKV TLNGVPAQPL GPRAQLLLKA
361 TPEDNGRSFS CSATLEVAGQ LIHKNQTREL RVLYGPRLDE RDCPGNWTWP ENSQQTPMCQ
421 AWGNPLPELK CLKDGTFPLP IGESVTVTRD LEGTYLCRAR STQGEVTRKV TVNVLSPRYE
481 IVIITVVAAA VIMGTAGLST YLYNRQRKIK KYRLQQAQKG TPMKPNTQAT PPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ICAM1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 234 nTPM
Expression across tissuesHPA
Tissue
- lung: 234 nTPM
- urinary bladder: 200 nTPM
- bone marrow: 111 nTPM
- adipose tissue: 93 nTPM
- liver: 67 nTPM
- spleen: 59 nTPM
Single-cell type
- neutrophils: 1,485 nCPM
- alveolar cells type 1: 906 nCPM
- alveolar cells type 2: 736 nCPM
- transitional alveolar cells: 696 nCPM
- monocytes: 568 nCPM
- vascular endothelial cells: 508 nCPM
Immune cell
- neutrophil: 41 nTPM
- classical monocyte: 28 nTPM
- intermediate monocyte: 26 nTPM
- myeloid DC: 25 nTPM
- total PBMC: 21 nTPM
- non-classical monocyte: 17 nTPM
Brain region
- thalamus: 22 nTPM
- medulla oblongata: 15 nTPM
- cerebral cortex: 14 nTPM
- white matter: 11 nTPM
- pons: 11 nTPM
- spinal cord: 11 nTPM
ReferencesPubMed · IEDB
Publications for ICAM1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
9 publications
- Soluble forms of intercellular adhesion molecule-1 in insulin-dependent diabetes mellitus.
1994 · Lancet · RCR 2.3 · 98 citations - Agonistic anti-ICAM-1 antibodies in scleroderma: activation of endothelial pro-inflammatory cascades.
2013 · Vascul Pharmacol · RCR 1.1 · 34 citations - Regulation of the local immune response by retinal cells.
1990 · Curr Eye Res · RCR 1 · 34 citations - CD11a expression and soluble ICAM-1 levels in peripheral blood in high-risk and overt type 1 diabetes subjects.
1999 · Immunol Lett · RCR 0.7 · 30 citations - Antibodies to proteinase-3 mediate expression of intercellular adhesion molecule-1 (ICAM-1, CD 54).
1997 · Br J Rheumatol · RCR 0.6 · 21 citations
Show 4 more
- Effective treatment of experimental lupus nephritis by combined administration of anti-CD11a and anti-CD54 antibodies.
1997 · Clin Exp Immunol · RCR 0.6 · 23 citations - Amplified expression of intercellular adhesion molecule-1 (ICAM-1) and M(r) 40K protein by DLD-1 colon tumor cells by interferon-gamma.
1993 · Cell Immunol · RCR 0.3 · 9 citations - Different roles for LFA-1 and VLA-4 integrins in T-B-cell interactions in vivo.
1999 · Immunology · RCR 0.1 · 5 citations - ICAM-1 autoantibodies detected in healthy individuals and cross-react with functional epitopes.
2025 · Immunohorizons · 1 citations
Reference: B cellIEDB
1 publication
- ICAM-1 autoantibodies detected in healthy individuals and cross-react with functional epitopes.
2025 · Immunohorizons · 1 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.62
- gnomAD pLI
- 0.04
- gnomAD missense Z
- 0.02
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adhesion of symbiont to host
- cell adhesion
- cell-cell adhesion mediated by integrin
- cellular response to amyloid-beta
- cellular response to glucose stimulus
- cellular response to leukemia inhibitory factor
- establishment of endothelial barrier
- heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules
- leukocyte adhesion to vascular endothelial cell
- leukocyte cell-cell adhesion
- leukocyte migration
- membrane to membrane docking
- negative regulation of endothelial cell apoptotic process
- negative regulation of extrinsic apoptotic signaling pathway via death domain receptors
- positive regulation of cellular extravasation
- positive regulation of ERK1 and ERK2 cascade
- receptor-mediated virion attachment to host cell
- regulation of ruffle assembly
- T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell
- T cell antigen processing and presentation
- T cell extravasation
- regulation of leukocyte mediated cytotoxicity
Molecular functions
- integrin binding
- receptor ligand activity
- signaling receptor activity
- transmembrane signaling receptor activity
- virus receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Immunoglobulin domain subtype
- Intercellular adhesion molecule/vascular cell adhesion molecule, N-terminal
- Intercellular adhesion molecule
- Intercellular adhesion molecule, N-terminal
- Immunoglobulin-like fold
- Immunoglobulin-like domain superfamily
- Intercellular adhesion molecule/vascular cell adhesion molecule
- Intercellular adhesion molecule 1/3/5, D2 domain
- Intercellular adhesion molecule (ICAM), N-terminal domain
- Immunoglobulin domain
- ICAM-1/3/5, D2 domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ICAM1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ICAM1 as an antibody target. Whether an autoantibody or antibody against ICAM1 could matter depends on whether native ICAM1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ICAM1 is annotated at the cell surface, where native ICAM1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ICAM1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...